Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1646-1651

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caputo, L.
Right arrow Articles by Lévy, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caputo, L.
Right arrow Articles by Lévy, B. I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1646-1651.)
© 1995 American Heart Association, Inc.


Articles

Angiotensin II Increases cGMP Content Via Endothelial Angiotensin II AT1 Subtype Receptors in the Rat Carotid Artery

Lidia Caputo; Joëlle Benessiano; Chantal M. Boulanger; Bernard I. Lévy

From the Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 141, Hôpital Lariboisière, Paris, France.

Correspondence to Dr Bernard Levy, INSERM Unit 141, Hôpital Lariboisière, 75010 Paris, France.

Abstract Angiotensin II (Ang II) has been reported to modulate cGMP formation in various types of cells. To acquire direct information on the intracellular transduction involved in this mechanism, we tested the effects of Ang II on vascular tone and on cGMP content of in vitro isolated carotid arteries from 12-week-old Wistar-Kyoto rats. Segments of carotid artery 20 mm long (n=8 for each group) maintained at a transmural pressure of 100 mm Hg were immersed in a bath (38°C) containing oxygenated Tyrode's solution. At the end of each experiment, the vessel diameter was measured, and the wall cGMP content was determined by enzyme immunoassay. Under basal conditions, mean diameter was 968±19 µm, and mean cGMP carotid artery content was 38.9±3.5 fmol/mg tissue. Incubation for 20 minutes with Ang II (10-5 mol/L) significantly increased cGMP wall content, twofold above the basal content (P<.01), and constricted the vessel (60±2.2% of the control diameter, P<.001). After preincubation with a nonselective antagonist of Ang II receptors, saralasin ([Sar1,Val5,Ala8]Ang II, 5x10-5 mol/L), or with a specific antagonist of Ang II AT1 receptor subtype, losartan (5x10-5 mol/L), carotid diameter and cGMP content were no longer affected by Ang II. Exposure of carotid arteries to a specific antagonist of Ang II AT2 receptor, PD 123319 (10-7 mol/L), modified neither Ang II–induced diameter decrease nor cGMP content increase. Constriction of the vessel with KCl (26±3%, P<.001) did not modify the basal cGMP wall content. Endothelium removal or incubation with NG-nitro-L-arginine methyl ester (10-3 mol/L) reduced the cGMP content (22±9%, P<.05 and 20±11%, P<.05, respectively); Ang II further decreased the diameter (P<.001) but no longer increased the cGMP content under these experimental conditions. The present study shows that Ang II constricts the carotid artery and increases cGMP level specifically via the Ang II AT1 receptor subtype in in vitro intact rat carotid artery. The mechanism underlying this increase in cGMP is thought to be mediated through endothelial NO synthase stimulation by Ang II.


Key Words: angiotensin II • cGMP • AT1 receptors • vasomotor tone • in vitro isolated carotid artery




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Ramchandran, T. Takezako, Y. Saad, L. Stull, B. Fink, H. Yamada, S. Dikalov, D. G. Harrison, C. Moravec, and S. S. Karnik
Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response
PNAS, December 12, 2006; 103(50): 19087 - 19092.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Bergaya, R. H.P. Hilgers, P. Meneton, Y. Dong, M. Bloch-Faure, T. Inagami, F. Alhenc-Gelas, B. I. Levy, and C. M. Boulanger
Flow-Dependent Dilation Mediated by Endogenous Kinins Requires Angiotensin AT2 Receptors
Circ. Res., June 25, 2004; 94(12): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Safar and P. Laurent
Pulse pressure and arterial stiffness in rats: comparison with humans
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1363 - H1369.
[Full Text] [PDF]


Home page
HypertensionHome page
M. Safar, P. Chamiot-Clerc, G. Dagher, and J. F. Renaud
Pulse Pressure, Endothelium Function, and Arterial Stiffness in Spontaneously Hypertensive Rats
Hypertension, December 1, 2001; 38(6): 1416 - 1421.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Henrion, N. Kubis, and B. I. Levy
Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation
Hypertension, November 1, 2001; 38(5): 1150 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Matrougui, L. Loufrani, C. Heymes, B. I. Levy, and D. Henrion
Activation of AT2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance Arteries
Hypertension, October 1, 1999; 34(4): 659 - 665.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. M. Boulanger, C. Heymes, J. Benessiano, R. S. Geske, B. I. Levy, and P. M. Vanhoutte
Neuronal Nitric Oxide Synthase Is Expressed in Rat Vascular Smooth Muscle Cells : Activation by Angiotensin II in Hypertension
Circ. Res., December 14, 1998; 83(12): 1271 - 1278.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Y. Qiu, D. Henrion, J. Benessiano, C. Heymes, B. Tournier, and B. I. Levy
Decreased Flow-Induced Dilation and Increased Production of cGMP in Spontaneously Hypertensive Rats
Hypertension, December 1, 1998; 32(6): 1098 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. E. Pueyo, J.-F. Arnal, J. Rami, and J.-B. Michel
Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells
Am J Physiol Cell Physiol, January 1, 1998; 274(1): C214 - C220.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. S. Cunha, H. Dabire, I. Bezie, A. M. Weiss, K. Chaouche-Teyara, S. Laurent, M. E. Safar, and P. Lacolley
Mechanical Stress of the Carotid Artery at the Early Phase of Spontaneous Hypertension in Rats
Hypertension, April 1, 1997; 29(4): 992 - 998.
[Abstract] [Full Text]